Aldrin Vasco Vidal

Dr. Aldrin Vasco Vidal

Leibniz institute for Plant Biochemistry
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
AVAldrin Vasco Vidal
Aldrin Vasco Vidal
CPCarlos S. Pérez
Carlos S. Pérez
FMFidel E. Morales
Fidel E. Morales
HGHilda E. Garay
Hilda E. Garay
DVDimitar Vasilev
Dimitar Vasilev
DRDaniel G. Rivera
Daniel G. Rivera

21 December 2018 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
AVAldrin Vasco Vidal
Aldrin Vasco Vidal
YMYanira Méndez
Yanira Méndez
APAndrea Porzel
Andrea Porzel
JBJochen Balbach
Jochen Balbach
LWLudger A. Wessjohann
Ludger A. Wessjohann
DRDaniel G. Rivera
Daniel G. Rivera

19 January 2018 in Chemical Science
Verified
Journal Article
Open access
PDF file
YMYanira Méndez
Yanira Méndez
JCJanoi Chang
Janoi Chang
AHAna R. Humpierre
Ana R. Humpierre
AZAbel Zanuy
Abel Zanuy
RGRaine Garrido
Raine Garrido
DRDaniel G. Rivera
Daniel G. Rivera
A new synthetic strategy for the development of multivalent antibacterial glycoconjugate vaccines is described. The approach comprises the utilization of an isocyanide-based multicomponent process for the conjugation of functionalized capsular polysaccharides of S. pneumoniae and S. Typhi to carrier proteins such as diphtheria and tetanus toxoids. For the first time, oxo- and carboxylic acid-functionalized polysaccharides could be either independently or simultaneously conjugated to immunogenic proteins by means of the Ugi-multicomponent reaction, thus leading to mono- or multivalent unimolecular glycoconjugates as vaccine candidates. Despite the high molecular weight of the two or three reacting biomolecules, the multicomponent bioconjugation proved highly efficient and reproducible. The Ugi-derived glycoconjugates showed notable antigenicity and elicited good titers of functional specific antibodies. To our knowledge, this is the only bioconjugation method that enables the incorporation of two different polysaccharidic antigens to a carrier protein in a single step. Applications in the field of self-adjuvanting, eventually anticancer, multicomponent vaccines are foreseeable.

1 February 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YMYanira Méndez
Yanira Méndez
GAGerman De Armas
German De Armas
IPIdalia Pérez
Idalia Pérez
TRTamara Rojas
Tamara Rojas
MVMario S. Valdés-Tresanco
Mario S. Valdés-Tresanco
DRDaniel G. Rivera
Daniel G. Rivera

24 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
LBLibby Brown
Libby Brown
AVAldrin Vasco Vidal
Aldrin Vasco Vidal
ADAna Laura Dias
Ana Laura Dias
TRTiago Rodrigues
Tiago Rodrigues
ASAnna Sigurdardottir
Anna Sigurdardottir
GBGonçalo J. L. Bernardes
Gonçalo J. L. Bernardes
Cyclization provides a general strategy for improving the proteolytic stability, cell membrane permeability and target binding affinity of peptides. Insertion of a stable, non-reducible linker into a disulphide bond is a commonly used approach for cyclizing phage-displayed peptides. However, among the vast collection of cysteine reactive linkers available, few provide the selectivity required to target specific cysteine residues within the peptide in the phage display system, whilst sparing those on the phage capsid. Here, we report the development of a cyclopropenone-based proximity-driven chemical linker that can efficiently cyclize synthetic peptides and peptides fused to a phage-coat protein, and cyclize phage-displayed peptides in a site-specific manner, with no disruption to phage infectivity. Our cyclization strategy enables the construction of stable, highly diverse phage display libraries. These libraries can be used for the selection of high-affinity cyclic peptide binders, as exemplified through model selections on streptavidin and the therapeutic target αvβ3.

11 September 2014 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
DRDaniel G. Rivera
Daniel G. Rivera
AVAldrin Vasco Vidal
Aldrin Vasco Vidal
RERadell Echemendía
Radell Echemendía
OCOdette Concepción
Odette Concepción
CPCarlos. S. Pérez
Carlos. S. Pérez
LWLudger A. Wessjohann
Ludger A. Wessjohann